Search tips
Search criteria 


Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Mech Ageing Dev. Author manuscript; available in PMC 2010 April 1.
Published in final edited form as:
Mech Ageing Dev. 2009 April; 130(4): 272–280.
doi:  10.1016/j.mad.2008.12.008
PMCID: PMC2768529

Changes in IL-15 expression and death-receptor apoptotic signaling in rat gastrocnemius muscle with aging and life-long calorie restriction


TNF-α-mediated apoptosis is enhanced in aged rodent muscles, suggesting that this pathway may be involved in sarcopenia. Interleukin-15 (IL-15), a muscle-derived anabolic cytokine, mitigates muscle wasting and apoptosis in cachectic rats. This effect is thought to occur through inhibition of TNF-α-triggered apoptosis. We investigated IL-15 signaling and the TNF-α-mediated pathway of apoptosis in the gastrocnemius muscle of Fischer344×Brown Norway rats across the ages of 8, 18, 29 and 37 months, in relation to life-long calorie restriction (CR, 40% calorie intake reduction). Aging caused loss of muscle mass and increased apoptotic DNA fragmentation, which were mitigated by CR. Protein levels of IL-15 and mRNA abundance of IL-15 receptor α-chain decreased in senescent ad libitum (AL) fed rats, but were maintained in CR rodents. Elevations of TNF-α, TNF-receptor 1, cleaved caspase-8 and -3 were observed at advanced age in AL rats. These changes were prevented or mitigated by CR. Our results indicate that aging is associated with decreased IL-15 signaling in rat gastrocnemius muscle, which may contribute to sarcopenia partly through enhanced TNF-α-mediated apoptosis. Preservation of IL-15 signaling by CR may therefore represent a further mechanism contributing to the anti-aging effect of this dietary intervention in skeletal muscle.

Keywords: sarcopenia, interleukin-15, tumor necrosis factor-α, calorie restriction, apoptosis


Sarcopenia, the loss of muscle mass and function, is a common feature of aging and is promoted by multiple etiological factors (e.g., denervation, altered hormonal status, impaired muscle regeneration, altered protein turnover, increased levels of pro-inflammatory cytokines, oxidative damage) [reviewed in (Rolland et al. 2008)]. However, the relative importance of the various contributing factors has not been established. In recent years, evidence has accumulated indicating that an age-dependent acceleration of apoptosis in skeletal muscle may be involved in the pathogenesis of sarcopenia (Strasser et al. 1999;Malmgren et al. 2001;Dirks and Leeuwenburgh 2002, 2004;Phillips and Leeuwenburgh 2005;Whitman et al. 2005;Siu et al. 2005a;Pistilli et al. 2006a;Marzetti et al. 2008a,b). Several apoptotic pathways may contribute to age-related muscle atrophy [reviewed in (Marzetti and Leeuwenburgh 2006)]. In particular, the death receptor-mediated pathway of apoptosis, triggered by TNF-α, is activated in skeletal muscle of old rodents (Phillips and Leeuwenburgh 2005;Pistilli et al. 2006a;Marzetti et al. 2008a), suggesting a role in age-related muscle loss. The relevance of TNF-α signaling to muscle atrophy is further highlighted by its ability to promote protein breakdown in skeletal myocytes (Li et al. 1998;Li and Reid 2000), mainly via activation of the ubiquitin-proteasome pathway (Llovera et al. 1997). The temporal relation between the initiation of apoptosis and the induction of proteolysis as well as the relative magnitude of the two processes during muscle wasting is still unclear. However, it has recently been suggested that apoptotic signaling is required for and precedes protein degradation during muscle atrophy (Argiles et al. 2008).

The death receptor pathway of apoptosis, also referred to as the extrinsic pathway, is triggered by the interaction of TNF-α with TNF-receptor 1 (TNF-R1) and subsequent recruitment of adaptor proteins such as Fas-associated death domain (FADD), TNF-receptor-associated death domain (TRADD) and TNF-receptor-associated factors (TRAFs). The resulting death-inducing signaling complex (DISC) engages and activates procaspase-8 (Danial and Korsmeyer 2004). Cleaved caspase-8 then works downstream to activate caspase-3, which carries out the actual proteolytic events and DNA fragmentation (via caspase-activated DNase, CAD) that result in cellular breakdown.

In the presence of strong pro-apoptotic pressure, such as aging or muscle unloading, skeletal myocytes may produce anti-apoptotic factors as an attempt to limit muscle loss (Dirks and Leeuwenburgh 2004;Siu et al. 2005a,b). In this regard, it was recently reported that expression of interleukin-15 (IL-15) mRNA, a muscle anabolic cytokine, was increased with unloading and aging in rat soleus and plantaris muscles (Pistilli et al. 2007). This finding was consistent with a previous microarray study in rodent soleus muscle (Pattison et al. 2003).

IL-15 belongs to the four-α-helix bundle cytokine family and acts as a growth factor for T and B lymphocytes, and for natural killer cells (Grabstein et al. 1994;Burton et al. 1994;Carson et al. 1994;Tagaya et al. 1996). Actions of IL-15 are transduced by a heterotrimeric receptor with two subunits shared with IL-2 [i.e., common γ-chain (γc) and IL-2 receptor β-chain (IL-2Rβ)] (Giri et al. 1994). The third subunit, IL-15 receptor α-chain (IL-15Rα), is responsible for IL-15 specificity and high affinity binding (Giri et al. 1995). In vitro studies showed that IL-15 promoted myosin heavy chain accumulation in differentiated myotubes independent of IGF-1 (Quinn et al. 1995). Quinn et al. (2002) also demonstrated that overexpression of IL-15 in cultured myotubes stimulated protein synthesis and inhibited proteolysis. Interestingly, IL-15 administration attenuated muscle wasting and apoptotic DNA fragmentation in a rat model of cancer cachexia (Figueras et al. 2004).

The anti-apoptotic effect of IL-15 in skeletal muscle may be mediated by inhibition of the TNF-α-mediated pathway. In fact, attenuation of apoptosis severity in muscle of cachectic rats supplemented with IL-15 coincided with decreased expression of TNF-R1 and R2 (Figueras et al. 2004). Furthermore, binding of IL-15 to its receptor enables IL-15Rα to compete with TNF-R1 for adaptor proteins of the DISC in cultured fibrosarcoma cells (Bulfone-Paus et al. 1999), thus preventing activation of downstream caspases. It was also demonstrated that interaction between IL-15Rα and TNF-R1-associated TRAF-2 resulted in activation of NF-κB (Bulfone-Paus et al. 1999). Notably, NF-κB may promote the expression of anti-apoptotic genes such as cellular inhibitor of apoptosis protein-1 and 2 (cIAP-1, cIAP-2), and FLICE-like inhibitory protein long form (FLIPL) (Wang et al. 1998;Micheau et al. 2001).

Based on these premises, we investigated the effects of aging and life-long calorie restriction (CR), an intervention shown to mitigate apoptosis in skeletal muscle of old rodents (Dirks and Leeuwenburgh 2004;Phillips and Leeuwenburgh 2005), on IL-15 expression and the apoptotic pathway activated by TNF-α in rat gastrocnemius muscle. We hypothesized that advanced age would be associated with decreased expression of IL-15 and IL-15Rα, concomitant with increased signaling through the TNF-α-mediated pathway of apoptosis. We further hypothesized that CR would attenuate apoptosis via downregulation of the TNF-α pathway of cell death, accompanied by upregulation of IL-15 and IL-15Rα expression.



Seventy-two 8, 18, 29 and 37-month-old male Fischer344×Brown Norway (F344×BNF1) hybrid rats were purchased from the NIA colony at Harlan Industries (Indianapolis, IN). The ages were chosen to reflect a young age (8-month), adulthood (18-month), advanced age (29-month) and senescence (37-month) (Turturro et al. 1999). In each age group, 9 animals were fed ad libitum (AL) and 9 were 40% calorie restricted (CR). CR was initiated at 14 weeks of age at 10% restriction, increased to 25% at 15 weeks, and to 40% at 16 weeks. AL rats had free access to NIH-31 average nutrient composition pellets, whereas CR animals received NIH-31/NIA fortified pellets, once daily, approximately 1 hour before the onset of the dark period. All rats had free access to tap water. Rats were individually housed and maintained on a 12-hour light/dark cycle, at constant temperature and humidity, in a facility approved by the Association for Assessment and Accreditation of Laboratory Animal Care. Health status, body weight and food intake were monitored daily. All procedures were in compliance with the Guide for the Care and Use of Laboratory Animals published by the NIH and reviewed and approved by the University of Florida's animal care and use committee.

Preparation of subcellular fractions and whole cell homogenates

Rats were sacrificed by rapid decapitation, hind limb muscles removed, trimmed of adipose tissue and tendons, and weighed. Immediately afterward, muscles were snap-frozen in liquid nitrogen and subsequently stored at -80°C. No major pathologies were noted at the time of tissue harvesting. Experiments were performed on the left medial gastrocnemius, predominantly comprised of type II fibers, which undergoes substantial atrophy during aging (Siu et al. 2006;Marzetti et al. 2008b). Subcellular fractionation and preparation of whole cell homogenates were performed as previously described (Marzetti et al. 2008b).

Western blot analysis

For quantification of TNF-R1 expression, 60 μg of protein were applied to pre-cast Tris·HCl gels (Bio-Rad, Hercules, Ca), whereas 120 μg were loaded to quantify cleaved caspase-8 and -3. Tissue levels of cIAP-1/2 and FLIPL as well as nuclear content of NF-κB p65 were determined by applying 100 μg of protein. Separated proteins were transferred to PVDF membranes (Immobilon P, Millipore, Bedford, MA, USA) using a semidry blotter (Bio-Rad). Transfer efficiency was verified by staining the gels with GelCode Blue Stain Reagent (Pierce Biotechnology, Rockford, IL) and the membranes with Ponceau S (Sigma-Aldrich, St. Louis, MO). Ponceau S staining was also used as a loading control (Moore and Viselli 2000). For TNF-R1 and cIAP-1/2 experiments, membranes were blocked in StartingBlock Tris-Buffered Saline Blocking Buffer with 0.05% Tween-20 (Pierce Biotechnology), and incubated in rabbit polyclonal anti-TNF-R1 (Abcam, Cambridge, MA), 1:1,000, and goat polyclonal anti-cIAP-1/2 (Santa Cruz Biotechnology, Santa Cruz, CA), 1:200, respectively. Membranes were subsequently incubated with alkaline phosphatase-conjugated secondary anti-rabbit (1:30,000; Sigma-Aldrich) and anti-goat (1:5,000; Santa Cruz Biotechnology) antibodies, respectively. For the analysis of cleaved caspase-8 and 3, NF-κB p65 and FLIPL, the Vectastain ABC-AmP immunodetection kit (Vector Laboratories) was used, according to the manufacturer's instructions. The following primary antibodies and relative dilutions were used: rabbit polyclonal anti-cleaved caspase-8 (Abcam), 1:1,000; rabbit monoclonal anti-cleaved caspase-3 (Cell Signaling Technology, Beverly, MA), 1:1,000; mouse monoclonal anti-NF-κB p65 (Santa Cruz Biotechnology), 1:200; rabbit polyclonal anti-FLIPL (Santa Cruz Biotechnology), 1:200. Generation of the chemiluminescent signal, digital acquisition and densitometry analysis were performed as previously described (Marzetti et al. 2008b). Spot density of the target bands was normalized to the amount of protein loaded in each lane, as determined by densitometric analysis of the corresponding Ponceau S-stained membranes.

Multiplexed immunoassay for cytokine quantification

Gastrocnemius protein levels of IL-15 and TNF-α were determined via a multiplexed, bead-based immunoassay (Bio-Rad). This assay allows for the simultaneous quantification of multiple analytes by a dual-laser fluorescent microsphere detection system (Bio-Rad). Briefly, ~50 mg of frozen tissue were pulverized using a dry ice-chilled BioPulverizer (BioSpec Products, Bartlesville, OK). The powder was suspended in 500 μL Bio-Plex Lysis solution with protease inhibitors (Bio-Rad), frozen at -80°C, thawed on ice and sonicated 20 times (duty cycle=40, output=4). Debris and lipid were removed by centrifugation at 20,800×g for 30 min at 4°C. The resulting supernatant was collected and stored at -80°C. Protein concentration was determined by the BCA Protein Assay (Pierce Biotechnology), and protein content normalized to 3 mg/ml. Concentration of TNF-α and IL-15 was determined by using rat TNF-α and mouse IL-15 assay kits (Bio-Rad), respectively. The use of the mouse IL-15 assay for detection of rat IL-15 had been previously validated with recombinant rat IL-15 (Cell Sciences, Canton, MA), yielding R2=0.9985 (data not shown). Standard curves for each analyte were run concurrently for all the assays, and all samples were run in triplicate. Intra- and inter-assay coefficients of variation were less than 20% and 30%, respectively. Cross-reactivity between the cytokines was negligible, as indicated by the absence of fluorescence above the background when using the BioRad Mouse Cytokine II standard dilutions (which includes recombinant mouse IL-15) with the rat TNF-α system (BioRad antibody-conjugated beads and detection antibody). Additionally, no fluorescence above the background was detected with the BioRad Rat Cytokine standard dilutions (which includes recombinant rat TNF-α) when used with the mouse IL-15 system (BioRad antibody-conjugated beads and detection antibody). Concentration of both analytes is expressed as pg/mg protein.

Cell death ELISA for quantification of DNA fragmentation

The extent of apoptotic DNA fragmentation was quantified in the gastrocnemius muscle by measuring the amount of cytosolic mono- and oligonucleosomes (180 base pair nucleotides or multiples) using an ELISA kit (Roche Diagnostics, Mannheim, Germany). This assay relies on the quantification of histone-complexed fragmented DNA. Although the kit does not allow for the discrimination between apoptotic vs. necrotic cell death in cytosolic extracts, occurrence of significant necrosis in skeletal muscle during normal aging has not been reported. Therefore, the impact of necrotic cell death in our system may be considered negligible. Absorbance was determined at 405 nm using a Synergy HT Multi-Detection microplate reader (BioTek, Winooski, VT) and reported as arbitrary OD units/mg cytosolic protein (apoptotic index).

Quantitative Polymerase Chain Reaction (Q-PCR)

To determine the relative gene expression of TNF-α, IL-15, γc, IL-2Rβ and IL-15Rα, Q-PCR analysis was performed. Total RNA was isolated and DNase-treated as previously described (Marzetti et al. 2008a). First strand cDNA synthesis was achieved from 2 μg of RNA using the MasterScript kit (5 Prime, Hamburg, Germany). Q-PCR was performed using an Applied Biosystems 7300 Real-Time PCR System (ABI, Foster City, CA). Amplification of cDNA was achieved using predesigned primers and probes (ABI, Table 1), employing ABI universal cycling conditions. All samples were examined in triplicate, with the young AL group as a calibrator. For all genes, negative controls (i.e., no template and no reverse transcriptase) were also included. Differences in the expression of the target genes were determined by the 2−ΔΔCT method (Livak and Schmittgen 2001) with β-actin as housekeeping gene, the expression of which did not change among the experimental groups (data not shown).

Table 1
Accession and catalogue numbers of the investigated genes. Amplicon length is also reported.

Statistical analysis

Statistical analysis was performed using GraphPrism 4.0.3 software (GraphPad Software, San Diego, CA). The experiments were fully crossed, two-factor designs, with four levels of age (8, 18, 29 and 37 months) and 2 levels of diet (AL and CR). The two-way analysis of variance (ANOVA) allowed for the distinction between age and diet effects as well as the determination of a possible interaction between the two factors. In cases where no interaction effect was observed, we reported whether there was a main age effect (independent of diet) and/or main diet effect (independent of age). When applicable, Bonferroni's post-hoc test was performed. Linear regression analyses were performed to explore correlations between variables. All tests were two-sided, with significance set at p<0.05. All data are reported as mean ± SEM.


Morphological characteristics

Body weight

Within each age group, CR rats weighed less than their AL counterparts (diet-effect: p<0.0001; Figure 1a). However, the trajectory of changes in body weight (BW) over time was different between diet groups (age×diet interaction: p<0.0001). In AL rats, BW increased from 8 to 29 months and declined thereafter (age-effect: p<0.0001). In contrast, in the CR group, BW remained relatively stable, with the exception of a small increase between 18 and 29 months.

Figure 1
Body weight (a), gastrocnemius absolute wet weight (b) and gastrocnemius muscle weight to body weight ratio (MW/BW, c) of 8, 18, 29 and 37-month-old Fischer344×Brown Norway rats. Letters indicate significant differences (p<0.05) within ...

Muscle weight

Gastrocnemius muscle absolute wet weight (MW) declined at advanced age, indicative of sarcopenia (age-effect: p<0.0001; Figure 1b). However, changes in MW with age were different in the two diet groups (age×diet interaction: p<0.0001). In AL rats, MW increased between 8 and 18 months, and declined thereafter. In contrast, in the CR group, MW remained unchanged until senescence, when a marked decrease was observed. Overall, CR animals displayed a lower MW in comparison to their AL counterparts (diet-effect: p<0.0001), except for the oldest animals, where no differences were detected. However, when MW was normalized to BW (MW/BW ratio), CR rats displayed a higher ratio relative to their AL controls in all age groups (diet-effect: p<0.0001; Figure 1c). MW/BW decreased over the course of aging in both AL and CR rats (age-effect: p<0.0001). However, AL animals displayed a steeper decline than their CR counterparts (age×diet interaction: p<0.0001). Overall, these data confirm and extend previous findings in this rodent model of aging demonstrating that CR attenuates sarcopenia (Mayhew et al. 1998;You et al. 2007).

Expression of IL-15 and IL-15 receptor subunits

Gastrocnemius protein and gene expression levels of IL-15 were analyzed to determine age and diet effects. Additionally, gene expression of the trimeric receptor subunits of IL-15 was determined.


mRNA levels of IL-15 did not change among groups (Table 2). However, protein levels of IL-15 declined with age in AL rats (age-effect: p<0.001; Figure 2a), but were not significantly changed in CR animals.

Figure 2
Muscle expression of IL-15 and IL-15Rα. Gastrocnemius protein content of IL-15 (a) decreased with aging in AL, but not in CR rats (age: p=0.0008; diet=0.39; interaction: p=0.11). Advanced age was also associated with reduced gene expression levels ...
Table 2
Gene expression of IL-15, common γc, IL-2Rβ and TNF-α in gastrocnemius muscle, as determined by Q-PCR analysis. No significant differences were detected for any of the genes in either age or diet groups. Data are mean ± ...

IL-15 receptor subunits

Gastrocnemius γc and IL-2Rβ mRNA expression was unchanged among the experimental groups (Table 2). However, an age×diet interaction was detected for IL-15Rα mRNA expression (p=0.02; Figure 2b). Specifically, we observed a progressive age-dependent decrease in IL-15Rα mRNA levels in the AL group that was significant at 37 months (age-effect: p=0.01). This decline was prevented by CR (diet-effect: p=0.04).

Expression of markers within the death receptor-mediated apoptosis

In order to investigate the effects of age and diet on the extrinsic pathway of apoptosis, muscle TNF-α mRNA and protein levels were evaluated by Q-PCR and the multiplexed immunoassay, respectively. Western blot analysis was performed to quantify protein expression of TNF-R1, cleaved caspase-8 and cleaved caspase-3.


TNF-α mRNA expression was unaffected by age and diet (Table 2). In contrast, TNF-α protein levels increased with advancing age (age-effect: p<0.0001; Figure 3a). However, this increase was attenuated in CR animals (diet-effect: p=0.02). No significant age×diet interaction was detected (p=0.26), possibly as a consequence of the small number of rats analyzed (5-6 per group).

Figure 3
Analysis of components of the TNF-α-mediated pathway of apoptosis. Gastrocnemius protein content of TNF-α (a) displayed an age-dependent increase, which was attenuated by CR (age: p<0.0001; diet=0.02; interaction: p=0.26). Content ...


An age×diet interaction (p<0.0001) was observed. Specifically, in AL rats, expression of TNF-R1 increased at 29 months compared to younger animals, and even further at 37 months (age-effect: p<0.0001; Figure 3b). Conversely, expression of TNF-R1 remained unchanged in CR rats.

Cleaved caspase-8

Muscle content of cleaved caspase-8 increased with advancing age (age-effect: p<0.0001; Figure 3c). However, there was an age×diet interaction (p<0.0001), reflective of a different pattern of changes over time between diet groups. In fact, in AL rats, levels of cleaved caspase-8 increased at 29 months compared to 8- and 18-month-old animals, with a further increase at 37 months. Conversely, in CR animals levels of cleaved caspase-8 were not elevated until senescence.

Cleaved caspase-3

Similar to cleaved caspase-8, cleaved caspase-3 levels displayed a different trajectory over the course of aging in AL and CR rats (age×diet interaction: p<0.0001; Figure 3d). Specifically, in the AL group, levels of cleaved caspase-3 increased with advancing age, starting at 29 months (age-effect: p<0.0001). Conversely, no changes were evident in CR animals across the age groups.

Activation of NF-κB and tissue levels of cIAP-1/2 and FLIPL

It was recently reported that, upon binding to IL-15, IL-15Rα induced NF-κB activation in cultured fibroblasts (Bulfone-Paus at al. 1999). Activation of NF-κB may result in enhanced transcription of anti-apoptotic genes such as cIAPs and FLIPL (Wang et al. 1998;Micheau et al. 2001). In order to evaluate the impact of age and CR on NF-κB activation, nuclear levels of p65, a subunit of the NF-κB heterodimer, were determined by Western blot analysis. Furthermore, muscle tissue levels of anti-apoptotic cIAP-1/2 and FLIPL were quantified.

Nuclear p65

A progressive age-dependent increase in nuclear p65 levels was evident (age-effect: p<0.0001; Figure 4a). However, nuclear p65 content was not correlated with either IL-15 protein levels (R2: 0.04, p=0.18; data not shown) or IL-15Rα gene expression (R2: 0.01, p=0.52; data not shown).

Figure 4
Muscle levels of nuclear NF-κB and anti-apoptotic proteins cIAP-1/2 and FLIPL. Gastrocnemius nuclear levels of NF-κB subunit p65 (a) displayed a progressive age-dependent increase (age: p<0.0001; diet: p=0.45; interaction: p= 0.15). ...

cIAP-1/2 and FLIPL

Gastrocnemius cIAP-1/2 content remained unchanged over the course of aging (Figure 4b). However, CR rats displayed higher levels compared to their AL controls (diet-effect: p=0.0006). In contrast, content of FLIPL did not change across age and diet groups (Figure 4c).

Apoptotic index

Internucleosomal DNA fragmentation represents a hallmark of apoptotic cell death. A sandwich ELISA was employed to quantify the amount of cytosolic mono- and oligonucleosomes. Values for the AL rats were previously published (Marzetti et al. 2008b). Data from CR rats, which were collected simultaneously, are presented here. As reported earlier (Marzetti et al. 2008b), apoptotic cell death was elevated at 29 months of age in AL rats compared to younger animals, with a further increase at 37 months (age-effect: p<0.0001; Figure 5). However, as a result of an age×diet interaction (p=0.001), apoptosis was not enhanced in CR animals until 37 months. The age-associated increase in DNA fragmentation was attenuated by CR (diet-effect: p<0.0001).

Figure 5
Gastrocnemius apoptotic index. Apoptotic DNA fragmentation increased with advancing age in AL rats starting at 29 months, whereas CR rats displayed an increase only at 37 months (age: p<0.0001; diet: p<0.0001: interaction: p=0.001). Letters ...

Regression analysis to explore the relationship among TNF-α, IL-15, apoptosis and gastrocnemius muscle atrophy

Regression analyses were performed to explore the hypothesis that TNF-α promoted apoptosis and muscle atrophy, whereas IL-15 partly mediated CR protection against muscle loss. First, the ratio between protein levels of TNF-α and IL-15 (TNF-α/IL-15) was calculated and its changes among groups evaluated. TNF-α/IL-15 increased at advanced age in AL, but not in CR rats (age-effect: p<0.0001; diet-effect: p=0.004; age×diet interaction: p=0.001; Figure 6). TNF-α/IL-15 was then used as the independent variable in regression analyses. A positive correlation was observed between TNF-α/IL-15 and the apoptotic index (R2: 0.41, p<0.0001; Figure 7a). Additionally, a negative correlation was detected between TNF-α/IL-15 and muscle weight (R2: 0.44, p<0.0001; Figure 7b). For this particular analysis, muscle weight in each dietary regimen was normalized to the average of their respective 8-month-old group, whose muscle weight was therefore considered as 100%. This procedure was adopted to minimize the possible confounding effect of differences in body weight between the two dietary groups. Finally, a negative correlation was evident between the apoptotic index and muscle weight expressed as described above (R2: 0.51, p<0.0001; Figure 7c). To ensure that the regressions were not solely driven by the 37-month-old AL group, the same analyses were run after excluding the senescent AL rats. TNF-α/IL-15 remained significantly correlated with both the apoptotic index (R2: 0.20, p=0.004) and muscle weight (R2: 0.12, p<0.05). Likewise, a significant negative correlation persisted between the apoptotic index and muscle weight (R2: 0.26, p<0.0001).

Figure 6
An age-dependent increase in TNF-α to IL-15 ratio was detected, which was prevented by CR (age: p<0.0001; diet: p=0.004; interaction: p=0.001). Letters indicate significant differences (p<0.05) within age groups, and between AL ...
Figure 7
Linear regression analysis revealed a negative correlation between TNF-α/IL-15 and muscle weight (MW) expressed as percentage of 8-month-old rats in the two dietary groups (a). A positive correlation was also detected between TNF-α/IL-15 ...


Chronic low-grade systemic inflammation has been indicated as a possible contributing factor to the development of sarcopenia (Roubenoff 2003). Among the pro-inflammatory cytokines, TNF-α has been suggested to be involved in the pathogenesis of age-related muscle atrophy (Visser et al. 2002), owing to its ability to promote muscle protein wasting (Llovera et al. 1993;Garcia-Martinez et al. 1993) and apoptosis (Carbo et al. 2002;Phillips and Leeuwenburgh 2005;Pistilli et al. 2006a;Marzetti et al. 2008a). On the contrary, IL-15, a cytokine highly expressed in skeletal muscle, inhibits muscle protein breakdown in various experimental models (Carbo et al. 2000;Quinn et al. 2002;Busquets et al. 2005) and mitigates apoptotic DNA fragmentation in tumor-bearing rats (Figueras et al. 2004). These actions have been attributed to the ability of IL-15 to counteract TNF-α signaling (Bulfone-Paus et al. 1997, 1999; Hiromatsu et al. 2003;Figueras et al. 2004).

In the present study, advanced age was associated with reduced protein expression of IL-15 and mRNA levels of IL-15Rα in rat gastrocnemius muscle. Enhanced TNF-α apoptotic signaling was also observed in old and senescent AL animals. In contrast, attenuation of sarcopenia and TNF-α apoptotic signaling in CR rats was accompanied by sustained protein levels of IL-15 and mRNA abundance of its receptor through senescence. Our hypothesis that the dynamic interaction between IL-15 and TNF-α might be relevant to apoptosis and muscle atrophy was supported by a positive correlation between the TNF-α to IL-15 ratio (TNF-α/IL-15) and the apoptotic index (R2: 0.41; p<0.0001; Figure 7a). Additionally, a negative and stronger correlation was detected between TNF-α/IL-15 and muscle weight (R2: 0.44; p<0.0001; Figure 7b). This observation highlights the multifaceted interaction between TNF-α and IL-15, which may encompass the regulation of apoptosis as well as muscle protein turnover. Based on these findings, it might be hypothesized that as a result of an age-related imbalance between TNF-α and IL-15, the loss of protein may be accelerated compared to the extent of apoptosis. Indeed, the relative magnitude of these processes in the context of sarcopenia is still unclear, but initiation of apoptosis appears to be required for the execution of muscle proteolysis (Argiles et al. 2008). However, changes in protein synthesis and degradation were not assessed in the present investigation. Additionally, the correlation between the apoptotic index and muscle weight was stronger (R2: 0.51, p<0.0001; Figure 7c) than observed between either TNF-α/IL-15 vs. muscle weight or TNF-α/IL-15 vs. the apoptotic index. This may indicate the existence of multiple apoptotic pathways operating simultaneously in aged skeletal muscle. However, the relative impact of each of these pathways in the pathogenesis of sarcopenia will require further investigation. Furthermore, in 29-month-old AL rats, elevation of the apoptotic index and activation of the death receptor signaling pathway were not accompanied by a significant increase in TNF-α/IL-15. It is possible that small changes in the levels of those cytokines had occurred, but were not detected by our multiplexed analysis. Alternatively, it may be hypothesized that production of inhibitory isoforms of IL-15Rα (Bulanova et al. 2007) might have taken place over the course of aging, resulting in a partial loss of IL-15 activity, in spite of its unaltered levels. However, our Q-PCR analysis was limited to total IL-15Rα gene expression and therefore we were unable to test this hypothesis.

With regard to the mechanisms whereby IL-15 may inhibit apoptosis, it has been shown that IL-15Rα can compete with TNF-R1 for DISC assembly (Bulfone-Paus et al. 1999), thus preventing the activation of the caspase cascade. Additionally, binding of IL-15 to IL-15Rα induced NF-κB activation via phosphorylation and subsequent degradation of the inhibitory subunit I-κBα (Bulfone-Paus et al. 1999). Notably, NF-κB can promote the expression of anti-apoptotic genes such as cIAPs and FLIPL (Wang et al. 1998;Micheau et al 2001). However, results from our study do not support the involvement of NF-κB activation as a protective mechanism against age-related skeletal muscle loss. In fact, nuclear levels of p65, a subunit of the NF-κB heterodimer were not correlated with either protein content of IL-15 or IL-15Rα gene expression. In addition, content of FLIPL and cIAP-1/2 remained unchanged over the course of aging. The discrepancies between our study and findings from Bulfone-Paus et al. (1999) can be explained by the different experimental models used (i.e., gastrocnemius muscle vs. cultured fibrosarcoma cells). In addition, it is possible that deflection of TNF-α signaling toward NF-κB might represent an acute anti-apoptotic response induced by IL-15. In this context, the finding by Pistilli et al. (2007) of increased IL-15 mRNA abundance following muscle unloading may be interpreted as an acute anti-apoptotic adaptation. In contrast, life-long CR in our study could have induced a chronic IL-15 stimulation, which may have resulted in downregulation of TNF-R1 expression and subsequent mitigation of the extrinsic pathway of apoptosis. The occurrence of such an adaptation was indeed reported by Figueras et al. (2004) following one week of IL-15 administration to tumor-bearing rats.

Elucidation of the actions of IL-15 on skeletal muscle is complicated by the existence of several splice variants of both the cytokine and IL-15Rα (Quinn 2008). Furthermore, translation of IL-15 mRNA is intrinsically inefficient, which may explain the lack of correlation reported between its mRNA and protein levels (Tagaya et al. 1996, 1997;Meazza et al. 1997;Riechman et al. 2004), which was also apparent in our study. Furthermore, it was demonstrated that co-expression of IL-15 and IL-15Rα resulted in increased stability of the two molecules (Bergamaschi et al. 2008). It may therefore be hypothesized that the age-related decrease in IL-15Rα expression observed in senescent AL rats might have resulted in a decline in IL-15 protein levels without corresponding changes in mRNA abundance. Taken together, our findings confirm that IL-15 protein levels cannot be inferred from assays of IL-15 mRNA expression.

Based on our results and the current literature, it might be hypothesized that preservation of IL-15 signaling late in life may counteract sarcopenia at least partly by mitigating the death receptor-mediated pathway of apoptosis (Figure 8). Specifically, chronic IL-15 stimulation may result in downregulation of TNF-R1 and subsequent prevention of TNF-α-mediated apoptosis. Sustained expression of IL-15Rα appears to be required for IL-15 signal stabilization (Bergamaschi et al. 2008). In addition to participating in the heterotrimeric signaling complex, IL-15Rα can also appear on the cell surface independently of the γc/IL-2Rβ. In this case, IL-15Rα can present IL-15 to adjacent cells (and perhaps flanking regions of a muscle fiber) expressing the γc/IL-2Rβ heterodimer in a juxtacrine mode of action (Budagian et al. 2006;Bulfone-Paus et al. 2006). Moreover, IL-15Rα can also exist in a soluble form (sIL-15Rα), which appears to be important for secretion, stabilization, and activity of IL-15 (Bergamaschi et al. 2008). A role for membrane-associated or soluble IL-15/IL-15Rα complexes is equally consistent with our data, and compatible with the hypothesis that decreased expression of IL-15Rα in muscle tissue during aging may be involved in increased apoptosis and sarcopenia.

Figure 8
Proposed interplay between IL-15 and TNF-α signaling in skeletal muscle. Binding of TNF-α to TNF-R1 triggers the extrinsic pathway of apoptosis. Chronic IL-15 stimulation may result in downregulation of TNF-R1 and subsequent prevention ...

Other aspects of our study deserve further discussion. First of all, we conducted our analyses on a predominantly type II muscle. Therefore, our findings may not be generalized to predominantly slow-myosin-containing muscles. Additionally, the increased extent of apoptosis observed in the gastrocnemius muscle of senescent CR rats (Figure 5), albeit much less severe as compared to the AL animals, was not accompanied by caspase-3 cleavage (Figure 3d). This may suggest the involvement of caspase-independent apoptogenic mediators such as apoptosis inducing factor (AIF) and endonuclease G (Marzetti et al. 2008c). Furthermore, in the 37-month-old CR rats, caspase-8 cleavage was not coupled with elevations in cleaved caspase-3. FLIPL (Micheau et al. 2002) and c-IAPs (Wang et al. 1998) have been shown to inhibit caspase-8 activity. However, expressions levels of those proteins were not reduced in senescent CR rats as compared to younger pair-fed animals. Alternatively, inhibition of caspase-8 activity may be attributable to the apoptosis repressor with caspase recruitment domain (ARC) (Koseki et al. 1998), whose cytosolic levels were increased in the gastrocnemius muscle of old CR F344 rats compared to AL controls (Dirks and Leeuwenburgh 2004). Finally, the assay employed to determine apoptosis provided a comprehensive quantification of DNA fragmentation. Therefore, it cannot be excluded that apoptosis in other cell types (e.g., endothelial and interstitial cells) may have contributed to the apoptotic index. However, studies employing TUNEL staining have confirmed that the extent of apoptosis is indeed elevated in skeletal muscles of old F344×BNF1 rats (Leeuwenburgh et al. 2005;Rice and Blough 2006;Pistilli et al. 2006b).


Results from our study indicate that production of IL-15 and expression of IL-15Rα in gastrocnemius muscle decrease over the course of aging, which might contribute to the loss of muscle mass. Furthermore, our findings suggest that preservation of IL-15 signaling late in life may represent an additional means underlying the protective effect of CR against age-related muscle loss, possibly via downregulation of TNF-α-mediated apoptosis.

Unexpectedly, in a very recent study, continuous infusion of human IL-15 into aging rats for two weeks appeared to stimulate, rather than suppress, muscle apoptosis (Pistilli and Alway 2008). It is possible that heterologous IL-15 may have functioned as an IL-15 antagonist in the rat system, or that continuous infusion of IL-15 further downregulated IL-15Rα in that study (Kumaki et al. 1996). Additionally, it may be hypothesized that, with reduced signaling or stabilization conferred by IL-15Rα in old rats (Rubinstein et al. 2006;Bergamaschi et al. 2008), IL-15 infusion had paradoxical effects on apoptosis. These conflicting findings underlie the importance of examining expression of all components of the IL-15 signaling apparatus, including IL-15 and its three receptor subunits. Clearly, further research is required to elucidate the complexity of IL-15 activity in aged skeletal muscle and to test whether manipulation of IL-15 signaling may serve as a novel strategy to restore muscle mass and function at old age.


This research was supported by grants to CL (NIA R01-AG17994 and AG21042), CC (NIH R01-AG024526-02) and LQ (NIH R01-AG024136 and National Research Initiative Competitive Grant 2005-35206-15264 from the USDA Cooperative State Research, Education, and Extension Service Animal Growth and Nutrient Utilization Program), and by the Department of Veterans Affairs. EM, SW and HL are supported by the University of Florida Institute on Aging and Claude D. Pepper Older Americans Independence Center (1 P30 AG028740). The authors wish to thank Dr. Michael Daniels for assisting with the statistical analysis, and Drs. Tim Hofer and Stephane Servais for their critical input in the conduct of the study.


Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.


  • Argiles JM, Lopez-Soriano FJ, Busquets S. Apoptosis signalling is essential and precedes protein degradation in wasting skeletal muscle during catabolic conditions. Int J Biochem Cell Biol. 2008;40:1674–1678. [PubMed]
  • Bergamaschi C, Rosati M, Jalah R, Valentin A, Kulkarni V, Alicea C, Zhang GM, Patel V, Felber BK, Pavlakis GN. Intracellular interaction of interleukin-15 with its receptor alpha during production leads to mutual stabilization and increased bioactivity. J Biol Chem. 2008;283:4189–4199. [PubMed]
  • Budagian V, Bulanova E, Paus R, Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev. 2006;17:259–280. [PubMed]
  • Bulanova E, Budagian V, Duitman E, Orinska Z, Krause H, Ruckert R, Reiling N, Bulfone-Paus S. Soluble Interleukin IL-15Ralpha is generated by alternative splicing or proteolytic cleavage and forms functional complexes with IL-15. J Biol Chem. 2007;282:13167–13179. [PubMed]
  • Bulfone-Paus S, Bulanova E, Budagian V, Paus R. The interleukin-15/interleukin-15 receptor system as a model for juxtacrine and reverse signaling. Bioessays. 2006;28:362–377. [PubMed]
  • Bulfone-Paus S, Bulanova E, Pohl T, Budagian V, Durkop H, Ruckert R, Kunzendorf U, Paus R, Krause H. Death deflected: IL-15 inhibits TNF-alpha-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Ralpha chain. FASEB J. 1999;13:1575–1585. [PubMed]
  • Bulfone-Paus S, Ungureanu D, Pohl T, Lindner G, Paus R, Ruckert R, Krause H, Kunzendorf U. Interleukin-15 protects from lethal apoptosis in vivo. Nat Med. 1997;3:1124–1128. [PubMed]
  • Burton JD, Bamford RN, Peters C, Grant AJ, Kurys G, Goldman CK, Brennan J, Roessler E, Waldmann TA. A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. Proc Natl Acad Sci U S A. 1994;91:4935–4939. [PubMed]
  • Busquets S, Figueras MT, Meijsing S, Carbo N, Quinn LS, Almendro V, Argiles JM, Lopez-Soriano FJ. Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect. Int J Mol Med. 2005;16:471–476. [PubMed]
  • Carbo N, Busquets S, van Royen M, Alvarez B, Lopez-Soriano FJ, Argiles JM. TNF-alpha is involved in activating DNA fragmentation in skeletal muscle. Br J Cancer. 2002;86:1012–1016. [PMC free article] [PubMed]
  • Carbo N, Lopez-Soriano J, Costelli P, Busquets S, Alvarez B, Baccino FM, Quinn LS, Lopez-Soriano FJ, Argiles JM. Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer. 2000;83:526–531. [PMC free article] [PubMed]
  • Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenmann J, Grabstein K, Caligiuri MA. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med. 1994;180:1395–1403. [PMC free article] [PubMed]
  • Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116:205–219. [PubMed]
  • Dirks A, Leeuwenburgh C. Apoptosis in skeletal muscle with aging. Am J Physiol Regul Integr Comp Physiol. 2002;282:R519–R527. [PubMed]
  • Dirks AJ, Leeuwenburgh C. Aging and lifelong calorie restriction result in adaptations of skeletal muscle apoptosis repressor, apoptosis-inducing factor, X-linked inhibitor of apoptosis, caspase-3, and caspase-12. Free Radic Biol Med. 2004;36:27–39. [PubMed]
  • Figueras M, Busquets S, Carbo N, Barreiro E, Almendro V, Argiles JM, Lopez-Soriano FJ. Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats. FEBS Lett. 2004;569:201–206. [PubMed]
  • Garcia-Martinez C, Agell N, Llovera M, Lopez-Soriano FJ, Argiles JM. Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett. 1993;323:211–214. [PubMed]
  • Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D. Utilization of the beta and gamma chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J. 1994;13:2822–2830. [PubMed]
  • Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, DuBose R, Cosman D, Park LS, Anderson DM. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J. 1995;14:3654–3663. [PubMed]
  • Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri J. Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor. Science. 1994;264:965–968. [PubMed]
  • Hiromatsu T, Yajima T, Matsuguchi T, Nishimura H, Wajjwalku W, Arai T, Nimura Y, Yoshikai Y. Overexpression of interleukin-15 protects against Escherichia coli-induced shock accompanied by inhibition of tumor necrosis factor-alpha-induced apoptosis. J Infect Dis. 2003;187:1442–1451. [PubMed]
  • Koseki T, Inohara N, Chen S, Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci U S A. 1998;95:5156–5160. [PubMed]
  • Kumaki S, Armitage R, Ahdieh M, Park L, Cosman D. Interleukin-15 up-regulates interleukin-2 receptor alpha chain but down-regulates its own high-affinity binding sites on human T and B cells. Eur J Immunol. 1996;26:1235–1239. [PubMed]
  • Leeuwenburgh C, Gurley CM, Strotman BA, Dupont-Versteegden EE. Age-related differences in apoptosis with disuse atrophy in soleus muscle. Am J Physiol Regul Integr Comp Physiol. 2005;288:R1288–R1296. [PubMed]
  • Li YP, Schwartz RJ, Waddell ID, Holloway BR, Reid MB. Skeletal muscle myocytes undergo protein loss and reactive oxygen-mediated NF-kappaB activation in response to tumor necrosis factor alpha. FASEB J. 1998;12:871–880. [PubMed]
  • Li YP, Reid MB. NF-kappaB mediates the protein loss induced by TNF-alpha in differentiated skeletal muscle myotubes. Am J Physiol Regul Integr Comp Physiol. 2000;279:R1165–R1170. [PubMed]
  • Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402–408. [PubMed]
  • Llovera M, Lopez-Soriano FJ, Argiles JM. Effects of tumor necrosis factor-alpha on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst. 1993;85:1334–1339. [PubMed]
  • Llovera M, Garcia-Martinez C, Agell N, Lopez-Soriano FJ, Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun. 1997;230:238–241. [PubMed]
  • Malmgren LT, Jones CE, Bookman LM. Muscle fiber and satellite cell apoptosis in the aging human thyroarytenoid muscle: a stereological study with confocal laser scanning microscopy. Otolaryngol Head Neck Surg. 2001;125:34–39. [PubMed]
  • Marzetti E, Leeuwenburgh C. Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol. 2006;41:1234–1238. [PubMed]
  • Marzetti E, Groban L, Wohlgemuth SE, Lees HA, Lin M, Jobe H, Giovannini S, Leeuwenburgh C, Carter CS. Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats. Am J Physiol Regul Integr Comp Physiol. 2008a;294:R558–R567. [PubMed]
  • Marzetti E, Wohlgemuth SE, Lees HA, Chung HY, Giovannini S, Leeuwenburgh C. Age-related activation of mitochondrial caspase-independent apoptotic signaling in rat gastrocnemius muscle. Mech Ageing Dev. 2008b;129:542–549. [PMC free article] [PubMed]
  • Marzetti E, Lawler JM, Hiona A, Manini T, Seo AY, Leeuwenburgh C. Modulation of age-induced apoptotic signaling and cellular remodeling by exercise and calorie restriction in skeletal muscle. Free Radic Biol Med. 2008c;44:160–168. [PubMed]
  • Mayhew M, Renganathan M, Delbono O. Effectiveness of caloric restriction in preventing age-related changes in rat skeletal muscle. Biochem Biophys Res Commun. 1998;251:95–99. [PubMed]
  • Meazza R, Gaggero A, Neglia F, Basso S, Sforzini S, Pereno R, Azzarone B, Ferrini S. Expression of two interleukin-15 mRNA isoforms in human tumors does not correlate with secretion: role of different signal peptides. Eur J Immunol. 1997;27:1049–1054. [PubMed]
  • Micheau O, Lens S, Gaide O, Alevizopoulos K, Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol Cell Biol. 2001;21:5299–5305. [PMC free article] [PubMed]
  • Micheau O, Thome M, Schneider P, Holler N, Tschopp J, Nicholson DW, Briand C, Grutter MG. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J Biol Chem. 2002;277:45162–45171. [PubMed]
  • Moore MK, Viselli SM. Staining and quantification of proteins transferred to polyvinylidene fluoride membranes. Anal Biochem. 2000;279:241–242. [PubMed]
  • Pattison JS, Folk LC, Madsen RW, Booth FW. Selected Contribution: Identification of differentially expressed genes between young and old rat soleus muscle during recovery from immobilization-induced atrophy. J Appl Physiol. 2003;95:2171–2179. [PubMed]
  • Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005;19:668–670. [PubMed]
  • Pistilli EE, Jackson JR, Alway SE. Death receptor-associated pro-apoptotic signaling in aged skeletal muscle. Apoptosis. 2006a;11:2115–2126. [PubMed]
  • Pistilli EE, Siu PM, Alway SE. Molecular regulation of apoptosis in fast plantaris muscles of aged rats. J Gerontol A Biol Sci Med Sci. 2006b;61:245–255. [PMC free article] [PubMed]
  • Pistilli EE, Siu PM, Alway SE. Interleukin-15 responses to aging and unloading-induced skeletal muscle atrophy. Am J Physiol Cell Physiol. 2007;292:C1298–C1304. [PubMed]
  • Pistilli EE, Alway SE. Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem Biophys Res Commun. 2008;373:20–24. [PMC free article] [PubMed]
  • Quinn LS, Haugk KL, Grabstein KH. Interleukin-15: a novel anabolic cytokine for skeletal muscle. Endocrinology. 1995;136:3669–3672. [PubMed]
  • Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argiles JM. Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res. 2002;280:55–63. [PubMed]
  • Quinn LS. Interleukin-15: a muscle-derived cytokine regulating fat-to-lean body composition. J Anim Sci. 2008;86:E75–E83. [PubMed]
  • Rice KM, Blough ER. Sarcopenia-related apoptosis is regulated differently in fast- and slow-twitch muscles of the aging F344/N × BN rat model. Mech Ageing Dev. 2006;127:670–679. [PubMed]
  • Riechman SE, Balasekaran G, Roth SM, Ferrell RE. Association of interleukin-15 protein and interleukin-15 receptor genetic variation with resistance exercise training responses. J Appl Physiol. 2004;97:2214–2219. [PubMed]
  • Rolland Y, Czerwinski S, Van Kan AG, Morley JE, Cesari M, Onder G, Woo J, Baumgartner R, Pillard F, Boirie Y, Chumlea WM, Vellas B. Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging. 2008;12:433–450. [PubMed]
  • Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care. 2003;6:295–299. [PubMed]
  • Rubinstein MP, Kovar M, Purton JF, Cho JH, Boyman O, Surh CD, Sprent J. Converting IL-15 to a superagonist by binding to soluble IL-15R{alpha} Proc Natl Acad Sci U S A. 2006;103:9166–9171. [PubMed]
  • Siu PM, Pistilli EE, Butler DC, Alway SE. Aging influences cellular and molecular responses of apoptosis to skeletal muscle unloading. Am J Physiol Cell Physiol. 2005a;288:C338–C349. [PubMed]
  • Siu PM, Pistilli EE, Ryan MJ, Alway SE. Aging sustains the hypertrophy-associated elevation of apoptotic suppressor X-linked inhibitor of apoptosis protein (XIAP) in skeletal muscle during unloading. J Gerontol A Biol Sci Med Sci. 2005b;60:976–983. [PubMed]
  • Siu PM, Pistilli EE, Murlasits Z, Alway SE. Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. J Appl Physiol. 2006;100:907–916. [PubMed]
  • Strasser H, Tiefenthaler M, Steinlechner M, Bartsch G, Konwalinka G. Urinary incontinence in the elderly and age-dependent apoptosis of rhabdosphincter cells. Lancet. 1999;354:918–919. [PubMed]
  • Tagaya Y, Bamford RN, DeFilippis AP, Waldmann TA. IL-15: a pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity. 1996;4:329–336. [PubMed]
  • Tagaya Y, Kurys G, Thies TA, Losi JM, Azimi N, Hanover JA, Bamford RN, Waldmann TA. Generation of secretable and nonsecretable interleukin 15 isoforms through alternate usage of signal peptides. Proc Natl Acad Sci U S A. 1997;94:14444–14449. [PubMed]
  • Turturro A, Witt WW, Lewis S, Hass BS, Lipman RD, Hart RW. Growth curves and survival characteristics of the animals used in the Biomarkers of Aging Program. J Gerontol A Biol Sci Med Sci. 1999;54:B492–B501. [PubMed]
  • Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM, Newman AB, Nevitt M, Harris TB. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326–M332. [PubMed]
  • Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS., Jr NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680–1683. [PubMed]
  • Whitman SA, Wacker MJ, Richmond SR, Godard MP. Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age. Pflugers Arch. 2005;450:437–446. [PubMed]
  • You T, Sonntag WE, Leng X, Carter CS. Lifelong caloric restriction and interleukin-6 secretion from adipose tissue: effects on physical performance decline in aged rats. J Gerontol A Biol Sci Med Sci. 2007;62:1082–1087. [PubMed]